T 1402/22 of 08.08.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T140222.20240808
- Date of decision
- 8 August 2024
- Case number
- T 1402/22
- Online on
- 27 March 2025
- Petition for review of
- -
- Application number
- 17777119.3
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Stabilized non-protein clostridial toxin compositions
- Applicant name
- Allergan, Inc.
- Opponent name
- IPSEN PHARMA S.A.S.
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- Rules of procedure of the Boards of Appeal 2020 Art 013(2)European Patent Convention Art 56
- Keywords
- Amendment after notification of Art. 15(1) RPBA communication - exceptional circumstances (no)
Inventive step - (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent with the following claims and a description to be possibly adapted thereto:
Claims 1 to 16 of auxiliary request 2 filed on 28 October 2020 and maintained with the reply to the appeal.